Extended Data Fig. 1: Cumulative incidence estimates of major adverse liver outcomes in the overlap-weighted patients. | Nature Medicine

Extended Data Fig. 1: Cumulative incidence estimates of major adverse liver outcomes in the overlap-weighted patients.

From: Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis

Extended Data Fig. 1

A Kaplan Meier graph shows the cumulative incidence of the primary composite endpoint, incident MALO, in the nonsurgical control group and separately after Roux-en-Y gastric bypass and sleeve gastrectomy. P value is for overall 2-sided comparison of 3 groups from the Cox proportional hazards model.

Back to article page